Why the study?
Do bioresorbable vascular scaffolds improve in vivo eccentricity and symmetry indices compared to metallic stents?
Do bioresorbable vascular scaffolds improve in vivo eccentricity and symmetry indices compared to metallic stents?
Bioresorbable vascular scaffolds demonstrate improved symmetry and lower eccentricity compared to metallic stents at 6 months, without affecting short-term clinical outcomes.
BVS geometry advantages lack short-term MACE impact; hypothesis-generating and should not change stent selection.
The introduction of a new polymeric material in the design of BVS resulted in a lower eccentricity index and a higher symmetry index as compared to metallic stents, without detectable impact in MACE, at 6 months.
No takes yet. Share an insight, caveat, or question.
Brugaletta et al. (2011) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: